Login / Signup

A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects.

Jeffrey GudinCharles ArgoffJeffrey FudinEmileigh GreuberKip VoughtKalpana PatelSri Nalamachu
Published in: Journal of pain research (2020)
NCT04144192, NCT04149938.
Keyphrases
  • open label
  • clinical trial
  • phase ii
  • phase ii study
  • phase iii
  • wound healing